ArticleMolecular and clinical oncology2025

Durvalumab consolidation after chemoradiotherapy for locoregional recurrent non-small cell lung cancer.

Keiichiro Suminaga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.